Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Lidocaine vs TAP Block for Recovery After Outpatient Laparoscopic Surgery
NCT02053558Withdrawn
- Sponsor
- Northwestern University
- Start
- Nov 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Northwestern University. Primary endpoint: Quality of Recovery-40 Global Score at 24 hours. Planned start Nov 2014; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02053558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053558.